Related Experiment Video
Updated: Feb 2, 2026

Modeling Brain Metastasis Via Tail-Vein Injection of Inflammatory Breast Cancer Cells
Published on: February 4, 2021
BRMS1 coordinates with LSD1 and suppresses breast cancer cell metastasis
Rongfang Qiu1, Hang Shi1, Shuang Wang1
12011 Collaborative Innovation Center of Tianjin for Medical Epigenetics, Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Tianjin Medical University Tianjin 300070, China.
Abstract:
Breast carcinoma metastasis suppressor gene 1 (BRMS1) encodes an inhibitor of metastasis and is reported in many types of tumor metastasis. However, the mechanism of BRMS1-mediated inhibition of breast cancer metastasis at the transcriptional level remains elusive. Here, we identified using affinity purification and mass spectrometry (MS) that BRMS1 is an integral component of the LSD1/CoREST corepressor complex. Analysis of the BRMS1/LSD1 complex using high-throughput RNA deep sequencing (RNA-seq) identified a cohort of target genes such as VIM, INSIG2, KLK11, MRPL33, COL5A2, OLFML3 and SLC1A1, some of which are metastasis-related. Our results have showed that BRMS1 together with LSD1 are required for inhibition of breast cancer cell migration and invasion. Collectively, these findings demonstrate that BRMS1 executes transcriptional suppression of breast cancer metastasis by associating with the LSD1 and thus can be targeted for breast cancer therapy.
Insights
Breast carcinoma metastasis suppressor gene 1 (BRMS1) inhibits metastasis by forming a complex with LSD1. This complex suppresses genes involved in breast cancer cell migration and invasion, offering a therapeutic target.
Area of Science:
- Molecular Biology
- Oncology
- Gene Regulation
Background:
- Breast carcinoma metastasis suppressor gene 1 (BRMS1) is known to inhibit tumor metastasis.
- The precise molecular mechanisms underlying BRMS1's role in suppressing breast cancer metastasis, particularly at the transcriptional level, remain largely unelucidated.
Purpose of the Study:
- To elucidate the mechanism by which BRMS1 suppresses breast cancer metastasis.
- To identify the protein complex BRMS1 interacts with and its downstream transcriptional targets.
Main Methods:
- Affinity purification coupled with mass spectrometry (MS) to identify BRMS1 interacting proteins.
- High-throughput RNA deep sequencing (RNA-seq) to analyze gene expression changes upon BRMS1 complex formation.
- Functional assays to assess cell migration and invasion.
Main Results:
- BRMS1 was identified as a component of the LSD1/CoREST corepressor complex.
- RNA-seq analysis revealed that the BRMS1/LSD1 complex regulates a set of target genes, including metastasis-related genes like VIM, INSIG2, and COL5A2.
- BRMS1 and LSD1 are collectively essential for inhibiting breast cancer cell migration and invasion.
Conclusions:
- BRMS1 suppresses breast cancer metastasis through transcriptional regulation mediated by its association with the LSD1/CoREST complex.
- Targeting the BRMS1-LSD1 interaction presents a potential therapeutic strategy for breast cancer treatment.
Related Concept Videos
Coordination Number and Geometry
Lattice Centering and Coordination Number
Types of Unit Cells
Imagine taking a large number of identical...
Coordination Compounds and Nomenclature
Cytoskeletal Coordination in Cell Migration
Cells Coordinate Growth and Proliferation
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...

